MRIGX | VEXRX | MRIGX / VEXRX | |
Total Expense Ratio | 0.97 | 0.33 | 294% |
Annual Report Gross Expense Ratio | 0.97 | 0.33 | 294% |
Fund Existence | 12 years | 24 years | - |
Gain YTD | -7.255 | -4.539 | 160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 50000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 777M | 19.4B | 4% |
Annual Yield % from dividends | 0.00 | 0.54 | - |
Returns for 1 year | -3.22 | -4.58 | 70% |
Returns for 3 years | -0.84 | 16.73 | -5% |
Returns for 5 years | -4.42 | 12.41 | -36% |
Returns for 10 years | -13.02 | 8.95 | -145% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 66.87 | -0.43 | -0.64% |
Janus Henderson Global Life Sciences I | |||
EVSTX | 20.76 | -0.23 | -1.10% |
Allspring Disciplined US Core C | |||
LFGVX | 37.90 | -0.42 | -1.10% |
Lord Abbett Focused Growth R6 | |||
RGABX | 69.54 | -0.84 | -1.19% |
American Funds Growth Fund of Amer R2 | |||
SLLAX | 12.28 | -0.22 | -1.76% |
SEI Small Cap F (SIMT) |